Drugs / BCG
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04348370 | Apr 2020 → Apr 2023 | COVID-19 | Texas A&M University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BCG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04348370 ↗ |
| Modality | Vaccine | “BCG is a vaccine against tuberculosis” NCT04348370 ↗ |